Burning Rock Biotech (BNR) Consolidated Net Income (2019 - 2026)

Burning Rock Biotech's Consolidated Net Income history runs 8 years deep, the most recent figure standing at -$2.5 million for Q1 2026.

• In Q1 2026, Consolidated Net Income fell 36.89% year-over-year to -$2.5 million; the TTM figure through Mar 2026 stood at -$8.0 million (up 74.49% YoY), while the FY2025 annual figure was -$7.8 million, up 83.57% from the prior year.
• Consolidated Net Income for Q1 2026 stood at -$2.5 million, down from -$1.9 million in the prior quarter.
• The five-year high for Consolidated Net Income was -$1.3 million in Q2 2025, with the low at -$41.2 million in Q1 2022.
• The 5-year median for Consolidated Net Income is -$16.8 million (2024), against an average of -$17.1 million.
• The sharpest annual moves came in 2022 and 2025: Consolidated Net Income sank 57.61% in 2022, then soared 91.32% in 2025.
• Burning Rock Biotech's Consolidated Net Income stood at -$31.1 million in 2022, then grew by 27.46% to -$22.5 million in 2023, then soared by 57.06% to -$9.7 million in 2024, then surged by 79.87% to -$1.9 million in 2025, then retreated by 26.42% to -$2.5 million in 2026.
• Business Quant data shows BNR's Consolidated Net Income at -$2.5 million in Q1 2026, -$1.9 million in Q4 2025, and -$2.3 million in Q3 2025.